Platelets, leukocytes, and coagulation

Current Opinion in Hematology

Volumn 8, Issue 5, 2001, Pages 263-269

  Bouchard, Beth A ^a,b   Tracy, Paula B ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8A; BLOOD CLOTTING FACTOR 9; BLOOD CLOTTING FACTOR 9A; CD11B ANTIGEN; CD18 ANTIGEN; ENZYME; ENZYME PRECURSOR; FIBRIN; FIBRINOGEN; MEMBRANE PROTEIN; PADGEM PROTEIN; PROTEINASE; RECEPTOR; SERINE PROTEINASE; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

BLOOD; BLOOD CLOTTING; BLOOD VESSEL INJURY; COMPLEX FORMATION; HUMAN; LEUKOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOGENESIS; THROMBUS;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PLATELETS; LEUKOCYTES; MACROMOLECULAR SUBSTANCES; MODELS, BIOLOGICAL; MONOCYTES; PLATELET ACTIVATION; THROMBIN;

EID: 0034831048     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200109000-00001     Document Type: Review

References (77)

1. Surface-dependent reactions of the vitamin K-dependent enzyme complexes
2. The role of the membrane in the expression of the vitamin K-dependent enzymes
3. Platelet factor Xa receptor
4. The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity
5. Thrombin-catalyzed activation of single chain bovine factor V
6. The size of human factor VIII heterodimers and the effects produced by thrombin
7. Subunit structure of thrombin-activated human factor Villa
8. Activation of human factor IX (Christmas factor)
9. Human blood coagulation factor IX. Purification, properties, and mechanism of activation by activated factor XI
10. Role of calcium ions and the heavy chain of factor XIa in the activation of human coagulation factor IX
11. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action
12. The lipoprotein-associated coagulation inhibitor
13. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C
14. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C
15. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C
16. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V
17. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C
18. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection
19. Inactivation of human coagulation factor V by activated protein C
20. Structural and functional characterization of platelet receptor-mediated factor VIII binding
21. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin
22. Properties of the factor Xa binding site on human platelets
23. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation
24. Structure/function analyses of recombinant variants of human factor Xa: Factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles
25. Substitution of asparagine for arginine 347 of recombinant factor Xa markedly reduces factor Va binding
26. Identification of effector cell protease receptor-1. A leukocyte-distributed receptor for the serine protease factor Xa
27. Protease-dependent T cell activation: Ligation of effector cell protease receptor-1 (EPR-1) stimulates lymphocyte proliferation
28. Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa
29. The elusive factor Xa receptor: Failure to detect transcripts that correspond to the published sequence of EPR-1
30. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa
31. Contribution of platelet-derived factor Va to thrombin generation on immobilized collagen-and fibrinogen-adherent platelets
32. Molecular dissection of effector cell protease receptor-1 recognition of factor Xa. Assignment of critical residues involved in antibody reactivity and ligand binding
33. On the role of EPR-1 or an EPR-1-like molecule in regulating factor Xa incorporation into platelet Prothrombinase
34. Networking in the hemostatic system. Integrin αllbβ3 binds prothrombin and influences its activation
35. Prothrombin binding to human activated platelets
36. Surface expression and functional characterization of alpha-granule factor V in human platelets: Effects of ionophore A23187, thrombin, collagen, and convulxin
37. Not all platelets are equal procoagulants?
38. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation
39. Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa
40. Model for a factor IX activation complex on blood platelets: Dimeric conformation of factor XIa is essential
41. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin
42. Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII
43. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein
44. Factor XI and platelets: Evidence that platelets contain only minimal factor XI activity and antigen
45. Factor XI antigen and activity in human platelets
46. Human platelets and factor XI. Localization in platelet membranes of factor XI-like activity and its functional distinction from plasma factor XI
47. Molecular cloning of platelet factor XI, an alternative splicing product of the plasma factor XI gene
48. Purification and characterization of platelet factor XI
49. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals
50. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C
51. Regulation of platelet factor Va-dependent thrombin generation by activated protein C at the surface of collagen-adherent platelets
52. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding
53. The role of platelets and leukocytes in coagulation
54. The biology of P-selectin glycoprotein ligand-1: Its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction
55. A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets
56. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets
57. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation
58. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein
59. Tissue factor and factor VII initiation of coagulation
60. P-selectin induces the expression of tissue factor on monocytes
61. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages
62. Functional assembly of intrinsic coagulation proteases on monocytes and platelets. Comparison between cofactor activities induced by thrombin and factor Xa
63. Functional prothrombinase complex assembly on isolated monocytes and lymphocytes
64. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations
65. Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation
66. Adherent blood monocytes delay cleavage of normal factor Va and factor Va Leiden at Arg306 by activated protein C
67. Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C
68. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation
69. Factor Xa interacts with two sites on monocytes with different functional activities
70. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface
71. Binding of fibrinogen to human monocytes
72. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen
73. Fibrin down-regulates LPS- and PMA-induced tissue factor expression by blood mononuclear cells
74. Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: Role of reactive oxygen species
75. Tissue factor expression in human leukemic cells
76. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis
77. Possible role of platelet-activating factor in the in vivo expression of tissue factor in neutrophils